GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
Input momentum (manajer yang sebanding):
keluasan pemegang -4.3% ·
aliran saham +2.0% ·
posisi baru bersih -4.5%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +1 | 941.63M | $119.04B | +5 | −3 |
| Q1 2026 | 176 | +4 | 930.86M | $129.53B | +6 | −3 |
| Q4 2025 | 171 | 0 | 1.00B | $122.89B | +1 | — |
| Q3 2025 | 23 | -1 | 603.99M | $67.03B | — | −2 |
| Q2 2025 | 22 | -1 | 560.26M | $62.11B | — | −1 |
| Q1 2025 | 20 | 0 | 255.31M | $28.60B | — | — |
| Q4 2024 | 20 | +1 | 270.33M | $24.97B | +1 | — |
| Q3 2024 | 18 | 0 | 213.42M | $17.89B | — | — |
| Q2 2024 | 18 | — | 202.41M | $13.88B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 119.36M | — | $13.23B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasif) | 114.88M | — | $12.74B | 0.2% | n/c | 1 | SEC ↗ ×24 |
| 3 | Fidelity (FMR) ✦ | 59.96M | — | $6.65B | 0.4% | n/c | 1 | SEC ↗ ×8 |
| 4 | State Street Global Advisors ✦ (pasif) | 59.19M | -0.6% | $6.56B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Capital World Investors ✦ | 46.30M | -13.5% | $5.13B | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 37.53M | +37.2% | $4.16B | 0.8% | ▲ Add | 5 | SEC ↗ ×9 |
| 7 | Dodge & Cox ✦ | 30.82M | -5.7% | $3.42B | 1.9% | ▼ Trim | 5 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 29.21M | +2.5% | $3.23B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 23.59M | +60.4% | $2.62B | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Norges Bank ✦ (pasif) | 19.39M | -2.3% | $2.15B | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 5.67M | +4.0% | $628.23M | 0.8% | ▲ Add | 5 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 5.47M | +1.8% | $606.52M | 0.5% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 2.47M | +32.5% | $272.21M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 14 | Marshall Wace ✦ | 1.95M | +152.1% | $216.29M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | Adage Capital Partners ✦ | 1.45M | +10.1% | $161.12M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 764.15K | -69.9% | $84.72M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 700.23K | +54.3% | $77.63M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 18 | Bridgewater Associates ✦ | 666.30K | +32.5% | $73.87M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 426.58K | +690.1% | $47.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 282.20K | +12.4% | $31.29M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 164.73K | -67.8% | $18.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 10.70K | +54.0% | $1.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Two Sigma Investments | $4.86M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 61.30K saham, $8,543 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 1.60K lbr · $229,907
Officer · 600 lbr · $87,174
Officer · 800 lbr · $115,566
Officer · 3.00K lbr · $435,870
Officer, Director · 7.99K lbr · $1.19M
Officer, Director · 1.60K lbr · $236,014
Officer, Director · 5.41K lbr · $807,856
Director · 3.40K lbr · $504,296
Director · 3.12K lbr · $462,432
Director · 4.60K lbr · $684,590
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi